Company Overview of CHL Healthcare Partners
CHL Healthcare Partners is a venture capital firm specializing in seed, start-up, and early stage investments. The firm typically invests in healthcare sector with a focus on biotechnology, molecular healthcare services, and life sciences tools and services. It targets companies focusing on consumer convenience including consumer healthcare and elder care, companies providing specialized service or a new care setting including general hospitals, companies addressing shortfall of access to care and providing efficient solutions to the administration of healthcare, service and product businesses specializing in new technology, drugs, and medical device. It primarily invests in companies based ...
1055 Washington Boulevard
Stamford, CT 06901
Founded in 1997
Key Executives for CHL Healthcare Partners
Managing Partner and Partner
General Partner and Partner
Compensation as of Fiscal Year 2016.
CHL Healthcare Partners Key Developments
Mevion Medical Systems, HOPU Investments, YuanMing Capital, Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners Forms Joint Venture to Produce, Sell and Service Proton Therapy Systems for the Chinese Market
Aug 4 15
Mevion Medical Systems announced that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion. The investment was led by HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and existing U.S. investors Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Concurrent with the investment, Mevion and the lead investors will form a joint venture in China to produce, sell and service proton therapy systems for the Chinese market. HOPU and YuanMing have extensive experience investing in successful healthcare companies and offer a significant network of healthcare experience in China.
Similar Private Companies By Industry
Recent Private Companies Transactions
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries